Medicare Enrolled
Dr. Dianne Levisohn, MD
Dermatology · Poulsbo, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Levisohn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Levisohn?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Levisohn
Dr. Dianne Levisohn is a dermatology specialist in Poulsbo, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Levisohn performed 12,004 Medicare services across 3,534 unique beneficiaries.
Between the years covered by Open Payments, Dr. Levisohn received a total of $5,578 from 32 pharmaceutical and/or device companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Levisohn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in WA
$5,578 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,004
Medicare services
Top 4% in WA for dermatology
3,534
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~600 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Photodynamic therapy gel for precancerous skin | 6,400 | $1 | $4 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,268 | $5 | $17 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
978 | $59 | $230 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
886 | $92 | $330 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
701 | $42 | $168 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
296 | $29 | $150 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
270 | $81 | $290 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
204 | $71 | $266 |
| UV therapy with tar or petroleum jelly A treatment using ultraviolet radiation combined with the application of tar or petroleum jelly to the skin. |
166 | $96 | $305 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
143 | $37 | $145 |
| Light therapy to destroy precancerous skin growth This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous. |
116 | $97 | $370 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
111 | $302 | $580 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
82 | $1 | $16 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
49 | $66 | $285 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
40 | $39 | $135 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
40 | $11 | $50 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
39 | $38 | $144 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
37 | $122 | $456 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
28 | $86 | $319 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
26 | $237 | $790 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
20 | $87 | $379 |
| Pathology tissue examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis. |
20 | $9 | $140 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
17 | $79 | $333 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $118 | $425 |
| Shaving of skin growth, 1.1-2.0 cm This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs. |
15 | $102 | $365 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 14 | $139 | $482 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
11 | $67 | $264 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
11 | $115 | $721 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,578
Total received (2018-2024)
Avg $797/year across 7 years
Top 17% in WA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
268
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,098 (91.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$480 (8.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,229
2023
$793
2022
$622
2021
$733
2020
$724
2019
$728
2018
$748
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$298
ABBVIE INC.
$247
Boehringer Ingelheim Pharmaceuticals, Inc.
$141
Amgen Inc.
$87
Novartis Pharmaceuticals Corporation
$86
UCB, Inc.
$72
Biofrontera Inc.
$60
E.R. Squibb & Sons, L.L.C.
$59
SUN PHARMACEUTICAL INDUSTRIES INC.
$42
GENZYME CORPORATION
$32
Organon Llc
$26
Incyte Corporation
$24
Genentech USA, Inc.
$20
Lilly USA, LLC
$18
Dermavant Sciences, Inc.
$17
Top 3 companies account for 55.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$888
Janssen Biotech, Inc.
$713
Lilly USA, LLC
$545
ABBVIE INC.
$509
AbbVie, Inc.
$303
Ortho Dermatologics, a division of Bausch Health US, LLC
$259
UCB, Inc.
$245
Boehringer Ingelheim Pharmaceuticals, Inc.
$218
GENZYME CORPORATION
$198
AbbVie Inc.
$174
Regeneron Healthcare Solutions, Inc.
$169
Allergan Inc.
$157
Biofrontera Inc.
$156
LEO Pharma Inc.
$133
Incyte Corporation
$126
Novartis Pharmaceuticals Corporation
$117
E.R. Squibb & Sons, L.L.C.
$115
Galderma Laboratories, L.P.
$110
PFIZER INC.
$71
DERMIRA, INC.
$66
VYNE Pharmaceuticals Inc.
$49
Sun Pharmaceutical Industries Inc.
$45
SUN PHARMACEUTICAL INDUSTRIES INC.
$42
Organon Llc
$26
Almirall LLC
$24
MAYNE PHARMA INC.
$20
Genentech USA, Inc.
$20
SANOFI-AVENTIS U.S. LLC
$19
Kyowa Kirin, Inc.
$17
Dermavant Sciences, Inc.
$17
Celgene Corporation
$13
DUSA Pharmaceuticals, Inc.
$13
Top 3 companies account for 38.5% of all-time payments
Associated products mentioned in payments ›
AKLIEF · ALTRENO · AMELUZ · AMZEEQ · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · COSENTYX · Cimzia · DERMATITIS - DISEASE · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · Enbrel · HADLIMA · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · JUBLIA · LEXETTE · ODOMZO · OPZELURA · Otezla · POTELIGEO · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TARGRETIN · TREMFYA · Tremfya · VTAMA · XOLAIR · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatologists within 10 mi
192
Per 100K population
69.4
County median income
$98,546
Nearest hospital
HARRISON MEDICAL CENTER
7.6 mi
7.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Levisohn is a clinical cardiology specialist, with above-average Medicare volume (top 4% in WA), with low-engagement industry engagement in the top 17% of WA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Levisohn experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Levisohn performed 6,400 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Levisohn receive payments from pharmaceutical companies?
Yes. Dr. Levisohn received a total of $5,578 from 32 companies across 268 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Levisohn's costs compare to other dermatologists in Poulsbo?
Dr. Levisohn's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Levisohn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Poulsbo
Browse dermatologists in Poulsbo ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in WA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in WA
Which WA dermatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology